Uncategorized

Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders

Mayo Clinic and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, unveiled a multi-year joint development collaboration to develop new clinical tests for diseases and improve patient care.

Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders Read More »

Scroll to Top